AstraZeneca , the oncology and biopharmaceutical company, secured a major access win for Enhertu in England after the NHS reversed an ear ...
LONDON — The coronavirus vaccine being developed by AstraZeneca and the University of Oxford was found to be "highly" protective, potentially paving the way for a vaccine that is more affordable and ...
South Africa’s Health Ministry says the decision is based on a trial that found the vaccine offers limited protection for the ...
LONDON, Sept 17 (Reuters) - AstraZeneca and Daiichi Sankyo said on Thursday their breast cancer treatment Enhertu has been ...
LONDON (AP) — AstraZeneca said Monday that late-stage trials showed that its COVID-19 vaccine with Oxford University was up to 90% effective in preventing disease. The results are based on interim ...
The Oxford/AstraZeneca vaccine fails to prevent mild and moderate cases of the South African coronavirus strain, researchers said Sunday. The University of Witwatersrand, Johannesburg, which conducted ...
LONDON, Nov 27 (Reuters) - AstraZeneca's (AZN.L), opens new tab Fasenra, an injectable treatment for severe asthma, is more effective during attacks than the oral steroid that has been the standard of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results